查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
诊断心电图市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029
市场调查报告书
商品编码
1319304

诊断心电图市场 - 全球市场规模、份额、趋势分析、机会和预测报告，2019-2029

Diagnostic Electrocardiograph Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Product and Service ; By End User ; By Lead Type ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3个工作天内

价格
简介目录

到 2029 年，全球诊断心电图 (ECG) 市场规模将达到 113.3 亿美元

由于对即时护理 (POC) 心电图设备的需求不断增加、心电图技术进步的迅速采用以及心血管疾病 (CVD) 患病率的不断增加，全球诊断心电图 (ECG) 市场正在蓬勃发展。

领先的战略咨询和市场研究公司 BlueWeave Consulting 最近估计，2022 年全球诊断心电图 (ECG) 市场价值将达到 78.9 亿美元。 BlueWeave 预测，2023-2029 年预测期内，全球诊断心电图 (ECG) 市场规模将以 5.43% 的年复合成长率大幅增长，到 2029 年将达到 113.3 亿美元。全球诊断心电图 (ECG) 市场的主要增长促进因素包括心血管疾病 (CVD) 患病率的上升、老年人口的增加以及技术进步的快速采用。人口老龄化、医疗基础设施改善以及支持性报销政策进一步推动了诊断心电图机的全球市场增长。此外，心电图技术的持续进步和远程监控设备的引入预计将在短期内促进市场扩张。新兴经济体比发达经济体提供更大的增长潜力，而发达经济体的市场已接近饱和。这些地区预计将受益于有利的政府政策、不断增长的医疗保健支出、尚未开发的潜在市场等，为市场增长创造利润丰厚的机会。因此，这些方面预计将在预测期内推动整体市场的扩张。然而，心电图设备的高成本和心电图测试意识的缺乏预计将抑制整个市场的增长。

该报告的详细分析提供了有关全球诊断心电图（ECG）市场的增长潜力、未来趋势和统计数据的信息。它还涵盖了推动市场总规模预测的因素。该报告承诺为决策者提供全球诊断心电图（ECG）市场的最新技术发展以及行业见解，以做出明智的战略决策。它还分析了市场的增长促进因素、挑战和竞争力。

目录

第1章研究框架

第2章执行摘要

第3章全球诊断心电图（ECG）市场洞察

  • 行业价值链分析
  • DROC分析
    • 增长促进因素
      • 心血管疾病（CVD）患病率增加
      • 对即时 (POC) 心电图设备的需求不断增长
      • 心电图技术的技术进步
    • 抑制因素
      • 心电图设备成本高
      • 缺乏心电图意识
    • 机会
      • 开发具有先进功能的新型心电图设备
      • 拓展新兴市场
    • 任务
      • 严格的监管要求
      • 心电图关键技术专利到期
  • 技术进步/最新发展
  • 监管框架
  • 波特五力分析

第4章全球诊断心电图 (ECG) 市场概述

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
      • 静息心电图
      • 负荷心电图装置
      • 动态心电图监测仪
      • 嵌入式循环录音机
      • 事件监视器
      • MCT装置
      • 智能心电监护仪
    • 按最终用户
      • 医院
      • 诊所和心臟中心
      • 日间手术中心
      • 其他的
    • 按引线类型
      • 12导联心电图仪
      • 5导联心电图仪
      • 3 导联心电图设备
      • 6导联心电图仪
      • 单导联
      • 其他的
    • 按地区
      • 北美
      • 欧洲
      • 亚太地区 (APAC)
      • 拉丁美洲 (LATAM)
      • 中东和非洲 (MEA)

第5章北美诊断心电图（ECG）市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
    • 按最终用户
    • 按引线类型
    • 按国家/地区
      • 我们
      • 加拿大

第6章欧洲诊断心电图（ECG）市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
    • 按最终用户
    • 按引线类型
    • 按国家/地区
      • 德国
      • 英国
      • 意大利
      • 法国
      • 西班牙
      • 比利时
      • 俄罗斯
      • 荷兰
      • 其他欧洲国家

第7章亚太诊断心电图（ECG）市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
    • 按最终用户
    • 按引线类型
    • 按国家/地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳大利亚和新西兰
      • 印尼
      • 马来西亚
      • 新加坡
      • 越南
      • 亚太地区其他地区

第8章拉丁美洲诊断心电图（ECG）市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
    • 按最终用户
    • 按引线类型
    • 按国家/地区
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘鲁
      • 拉丁美洲其他地区

第9章中东和非洲诊断心电图（ECG）市场

  • 2019-2029年市场规模及预测
    • 按金额
  • 市场份额及预测
    • 按产品和服务
    • 按最终用户
    • 按引线类型
    • 按国家/地区
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 卡塔尔
      • 科威特
      • 南非
      • 尼日利亚
      • 阿尔及利亚
      • MEA 的其余部分

第10章竞争格局

  • 主要公司及其产品列表
  • 2022 年全球诊断心电图 (ECG) 市场份额分析
  • 通过运行参数进行竞争基准测试
  • 主要战略发展（合併、收购、合作伙伴关係等）

第11章COVID-19 对全球诊断心电图 (ECG) 市场的影响

第12章公司简介（公司简介、财务矩阵、竞争格局、关键人才、主要竞争、联繫地址、战略展望、SWOT分析）

  • Roche Diagnostics
  • Abbott Laboratories
  • Cepheid Inc.
  • BioMerieux SA
  • Hologic, Inc.
  • QIAGEN NV
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Sysmex Corporation
  • GenMark Diagnostics, Inc.
  • Grifols SA
  • Meridian Bioscience, Inc.
  • Luminex Corporation
  • T2 Biosystems, Inc.
  • Other Prominent Players

第13章关键战略建议

第14章调查方法

  • 定性研究
    • 初级和次级研究
  • 定量研究
  • 市场细分和数据三角测量
    • 二次调查
    • 初步调查
  • 主要调查受访者的地区分布
  • 假设和限制
简介目录
Product Code: BWC23608

Global Diagnostic Electrocardiograph (ECG) Market Size Set to Touch USD 11.33 Billion by 2029.

Global diagnostic electrocardiograph (ECG) market is flourishing, because of an increasing demand for point-of-care (POC) ECG devices, rapid adoption of technological advancements in ECG technology, and growing prevalence of cardiovascular diseases (CVDs).

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global diagnostic electrocardiograph (ECG) market size at USD 7.89 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the global diagnostic electrocardiograph (ECG) market size to grow at a significant CAGR of 5.43% reaching a value of USD 11.33 billion by 2029. Major growth drivers for the global diagnostic electrocardiograph (ECG) market include the rising prevalence of cardiovascular diseases (CVDs), growing geriatric population, and rapid adoption of advancements in technology. An increasing number of elderly individuals, improvements in healthcare infrastructure, and supportive reimbursement policies are further driving the global diagnostic ECG market growth. Also, the continuous advancements in ECG technology, along with the introduction of remote monitoring devices, are expected to contribute to the market's expansion in the foreseeable future. Compared to developed countries where the market is nearly saturated, developing nations offer significant growth prospects. These regions are expected to benefit from favorable government policies, increased healthcare expenditure, and largely untapped potential markets, thereby creating lucrative opportunities for market growth. Hence, such aspects are expected to boost the expansion of overall market during the forecast period. However, the high cost of ECG devices and lack of awareness about ECG testing are anticipated to restrain the overall market growth.

Global Diagnostic Electrocardiograph (ECG) Market - Overview:

The global diagnostic electrocardiograph (ECG) market refers to the worldwide market for medical devices used to measure and record the electrical activity of the heart, known as electrocardiograms (ECGs or EKGs). These devices are essential in assessing cardiac health, diagnosing heart conditions, and monitoring patients with cardiovascular diseases. The market encompasses a range of ECG devices, including resting ECG systems, stress ECG systems, Holter monitors, and event monitors. It plays a crucial role in early detection, diagnosis, and management of cardiovascular diseases, contributing to improved patient care and outcomes. The market is influenced by factors such as the prevalence of cardiovascular diseases, advancements in technology, aging population, and healthcare expenditure.

Impact of COVID-19 on Global Diagnostic Electrocardiograph (ECG) Market:

COVID-19 pandemic had a dual impact on the global diagnostic electrocardiograph (ECG) market. Initially, the market experienced a decline in demand due to the diversion of healthcare resources and priorities towards managing the pandemic. Many non-essential procedures, including routine cardiac screenings, were postponed or canceled. However, as the pandemic progressed, there had been a growing recognition of the importance of cardiac monitoring in COVID-19 patients, leading to increased demand for diagnostic electrocardiograph (ECG) devices. Additionally, the adoption of telemedicine and remote patient monitoring solutions surged, driving the need for portable and home-based ECG devices. These factors are expected to have a positive influence on the market's recovery and growth in the coming years.

Global Diagnostic Electrocardiograph (ECG) Market - By Lead Type:

Based on lead type, the global diagnostic electrocardiograph (ECG) market is divided into 12-lead ECG Devices, 5-lead ECG Devices, 3-lead ECG Devices, 6-lead ECG Devices, and Single-lead segments. The 3-lead ECG devices segment holds the highest share in the global diagnostic electrocardiograph (ECG) market by lead type. These devices are widely used and preferred in healthcare settings due to their simplicity and cost-effectiveness. They provide basic cardiac monitoring by measuring electrical activity from three specific leads, making them suitable for routine screenings and initial assessments. This makes them accessible and affordable for healthcare facilities, especially in resource-constrained settings. Also, 3-lead ECG devices are commonly utilized in various healthcare settings, including hospitals, clinics, and ambulatory care centers, where they offer quick and convenient ECG readings. Their ease of use, affordability, and versatility contribute to their dominant market share.

Competitive Landscape:

Major players operating in the global diagnostic electrocardiograph (ECG) market include: Roche Diagnostics, Abbott Laboratories, Cepheid Inc., BioMerieux SA, Hologic, Inc., QIAGEN N.V., Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Sysmex Corporation, GenMark Diagnostics, Inc., Grifols SA, Meridian Bioscience, Inc., Luminex Corporation, and T2 Biosystems, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the Global Diagnostic Electrocardiograph (ECG) Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Diagnostic Electrocardiograph (ECG) Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Diagnostic Electrocardiograph (ECG) Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases (CVDs)
      • 3.2.1.2. Rising demand for point-of-care (POC) ECG devices
      • 3.2.1.3. Technological advancements in ECG technology
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of ECG devices
      • 3.2.2.2. Lack of awareness about ECG testing
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of new ECG devices with advanced features
      • 3.2.3.2. Expansion into emerging markets
    • 3.2.4. Challenges
      • 3.2.4.1. Stringent regulatory requirements
      • 3.2.4.2. Patent expiration of key ECG technologies
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Diagnostic Electrocardiograph (ECG) Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share and Forecast
    • 4.2.1. By Product and Service
      • 4.2.1.1. Resting ECG
      • 4.2.1.2. Stress ECG Devices
      • 4.2.1.3. Holter Monitors
      • 4.2.1.4. Implantable Loop Recorders
      • 4.2.1.5. Event Monitors
      • 4.2.1.6. MCT Devices
      • 4.2.1.7. Smart ECG Monitors
    • 4.2.2. By End User
      • 4.2.2.1. Hospitals
      • 4.2.2.2. Clinics & Cardiac Centers
      • 4.2.2.3. Ambulatory Surgical Centers
      • 4.2.2.4. Others
    • 4.2.3. By Lead Type
      • 4.2.3.1. 12-lead ECG Devices
      • 4.2.3.2. 5-lead ECG Devices
      • 4.2.3.3. 3-lead ECG Devices
      • 4.2.3.4. 6-lead ECG Devices
      • 4.2.3.5. Single-lead
      • 4.2.3.6. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Diagnostic Electrocardiograph (ECG) Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product and Service
    • 5.2.2. By End User
    • 5.2.3. By Lead Type
    • 5.2.4. By Country
      • 5.2.4.1. United States
      • 5.2.4.1.1. By Product and Service
      • 5.2.4.1.2. By End User
      • 5.2.4.1.3. By Lead Type
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By Product and Service
      • 5.2.4.2.2. By End User
      • 5.2.4.2.3. By Lead Type

6. Europe Diagnostic Electrocardiograph (ECG) Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product and Service
    • 6.2.2. By End User
    • 6.2.3. By Lead Type
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By Product and Service
      • 6.2.4.1.2. By End User
      • 6.2.4.1.3. By Lead Type
      • 6.2.4.2. United Kingdom
      • 6.2.4.2.1. By Product and Service
      • 6.2.4.2.2. By End User
      • 6.2.4.2.3. By Lead Type
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By Product and Service
      • 6.2.4.3.2. By End User
      • 6.2.4.3.3. By Lead Type
      • 6.2.4.4. France
      • 6.2.4.4.1. By Product and Service
      • 6.2.4.4.2. By End User
      • 6.2.4.4.3. By Lead Type
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By Product and Service
      • 6.2.4.5.2. By End User
      • 6.2.4.5.3. By Lead Type
      • 6.2.4.6. Belgium
      • 6.2.4.6.1. By Product and Service
      • 6.2.4.6.2. By End User
      • 6.2.4.6.3. By Lead Type
      • 6.2.4.7. Russia
      • 6.2.4.7.1. By Product and Service
      • 6.2.4.7.2. By End User
      • 6.2.4.7.3. By Lead Type
      • 6.2.4.8. The Netherlands
      • 6.2.4.8.1. By Product and Service
      • 6.2.4.8.2. By End User
      • 6.2.4.8.3. By Lead Type
      • 6.2.4.9. Rest of Europe
      • 6.2.4.9.1. By Product and Service
      • 6.2.4.9.2. By End User
      • 6.2.4.9.3. By Lead Type

7. Asia-Pacific Diagnostic Electrocardiograph (ECG) Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By End User
    • 7.2.3. By Lead Type
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By Product and Service
      • 7.2.4.1.2. By End User
      • 7.2.4.1.3. By Lead Type
      • 7.2.4.2. India
      • 7.2.4.2.1. By Product and Service
      • 7.2.4.2.2. By End User
      • 7.2.4.2.3. By Lead Type
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By Product and Service
      • 7.2.4.3.2. By End User
      • 7.2.4.3.3. By Lead Type
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By Product and Service
      • 7.2.4.4.2. By End User
      • 7.2.4.4.3. By Lead Type
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By Product and Service
      • 7.2.4.5.2. By End User
      • 7.2.4.5.3. By Lead Type
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By Product and Service
      • 7.2.4.6.2. By End User
      • 7.2.4.6.3. By Lead Type
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By Product and Service
      • 7.2.4.7.2. By End User
      • 7.2.4.7.3. By Lead Type
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By Product and Service
      • 7.2.4.8.2. By End User
      • 7.2.4.8.3. By Lead Type
      • 7.2.4.9. Vietnam
      • 7.2.4.9.1. By Product and Service
      • 7.2.4.9.2. By End User
      • 7.2.4.9.3. By Lead Type
      • 7.2.4.10. Rest of APAC
      • 7.2.4.10.1. By Product and Service
      • 7.2.4.10.2. By End User
      • 7.2.4.10.3. By Lead Type

8. Latin America Diagnostic Electrocardiograph (ECG) Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By End User
    • 8.2.3. By Lead Type
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By Product and Service
      • 8.2.4.1.2. By End User
      • 8.2.4.1.3. By Lead Type
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By Product and Service
      • 8.2.4.2.2. By End User
      • 8.2.4.2.3. By Lead Type
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By Product and Service
      • 8.2.4.3.2. By End User
      • 8.2.4.3.3. By Lead Type
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By Product and Service
      • 8.2.4.4.2. By End User
      • 8.2.4.4.3. By Lead Type
      • 8.2.4.5. Rest of LATAM
      • 8.2.4.5.1. By Product and Service
      • 8.2.4.5.2. By End User
      • 8.2.4.5.3. By Lead Type

9. Middle East & Africa Diagnostic Electrocardiograph (ECG) Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By End User
    • 9.2.3. By Lead Type
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By Product and Service
      • 9.2.4.1.2. By End User
      • 9.2.4.1.3. By Lead Type
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By Product and Service
      • 9.2.4.2.2. By End User
      • 9.2.4.2.3. By Lead Type
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By Product and Service
      • 9.2.4.3.2. By End User
      • 9.2.4.3.3. By Lead Type
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By Product and Service
      • 9.2.4.4.2. By End User
      • 9.2.4.4.3. By Lead Type
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By Product and Service
      • 9.2.4.5.2. By End User
      • 9.2.4.5.3. By Lead Type
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By Product and Service
      • 9.2.4.6.2. By End User
      • 9.2.4.6.3. By Lead Type
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By Product and Service
      • 9.2.4.7.2. By End User
      • 9.2.4.7.3. By Lead Type
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By Product and Service
      • 9.2.4.8.2. By End User
      • 9.2.4.8.3. By Lead Type

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Diagnostic Electrocardiograph (ECG) Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Diagnostic Electrocardiograph (ECG) Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Roche Diagnostics
  • 12.2. Abbott Laboratories
  • 12.3. Cepheid Inc.
  • 12.4. BioMerieux SA
  • 12.5. Hologic, Inc.
  • 12.6. QIAGEN N.V.
  • 12.7. Becton, Dickinson and Company
  • 12.8. Danaher Corporation
  • 12.9. Thermo Fisher Scientific Inc.
  • 12.10. Sysmex Corporation
  • 12.11. GenMark Diagnostics, Inc.
  • 12.12. Grifols SA
  • 12.13. Meridian Bioscience, Inc.
  • 12.14. Luminex Corporation
  • 12.15. T2 Biosystems, Inc.
  • 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations